Target intelligence / Profile preview

Copper(I) ion (Cu+)

Target
Cu+
Molecular classification
Metal ion, Cofactor
01

Overview

Copper(I) ion, also known as the cuprous ion, is a monovalent metal cation that serves as an essential micronutrient and a critical cofactor for a variety of cuproenzymes, including cytochrome c oxidase and superoxide dismutase (PubChem CID 159561). It plays a fundamental role in cellular respiration, antioxidant defense, and iron metabolism by cycling between its Cu+ and Cu2+ oxidation states to facilitate electron transfer (NIH Office of Dietary Supplements). While essential, free copper is highly toxic due to its ability to generate reactive oxygen species, necessitating tight regulation by chaperones and transporters like ATP7A and ATP7B (UniProt). Clinical interest in Copper(I) centers on Wilson's disease, where copper accumulates to toxic levels, and emerging cancer therapies that utilize copper ionophores to trigger a unique form of regulated cell death called cuproptosis (Tsvetkov et al., Science 2022). Therapeutic interventions primarily focus on chelation therapy using agents like penicillamine to remove excess copper or the modulation of copper levels to disrupt tumor growth and signaling (StatPearls).

Other names
Cuprous ionCopper(1+)Cu(I)Monovalent copper
02

Mechanism of action

Chelation of copper ions to facilitate urinary or biliary excretion; induction of metallothionein to sequester copper; copper ionophore activity to increase intracellular copper and induce cuproptosis.

03

Biological functions

Enzyme catalysisRedox signalingEnergy metabolismIron homeostasisAntioxidant defenseAngiogenesis
04

Disease associations

Wilson's diseaseMenkes diseaseCancerAlzheimer's diseaseHepatotoxicity
05

Safety considerations

Copper deficiency-induced anemiaNeutropeniaNeurological deterioration during initial chelationNephrotoxicityHypersensitivity reactions
06

Interacting drugs

Penicillamine

5 more in the full profile.

07

Biomarkers

Serum ceruloplasmin24-hour urinary copperNon-ceruloplasmin bound copper (Free copper)Hepatic copper concentration

Beyond the preview

Go deeper on Copper(I) ion (Cu+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copper(I) ion (Cu+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call